2Krishna R,Mayer LD.Multidrug resistance (MDR) in cancer.Mechanisms,reversal using modulators of MDR and the role of MDR modulators in influencing the phartnecokinetics of anticancer drugs[J].Eur J Pharm Sci,2000,11(4):265-283. 被引量：1
3Gottesman MM,Fojo T,Bates SE.Multidrug resistance in cancer:role of ATP-dependent transporters[J].Nat Rev Cancer,2002,2(1):48-58. 被引量：1
4Mayur YC,Peters GJ,Prasad VV,et al.Design of new drug molecules to be used in reversing multidrug resistance in cancer cells[J].Curr Cancer Drug Targets,2009,9(3):298-306. 被引量：1
5Tucci M,Quatraro C,Dammacco F,et al.Role of active drug transporters in refractory multiple myeloma[J].Curr Top Med Chem,2009,9(2):218-224. 被引量：1
6Collins TR,Hammes GG,Hsieh TS.Analysis of the eukaryotic topoisomerase II DNA gate:a single-molecule FRET and structural perspective[J].Nucleic Acids Res,2009,37(3):712-720. 被引量：1
7Sánchez C,Mendoza P,Contreras HR,et al.Expression of multidrug resistance proteins in prostate cancer is related with cell sensitivity to chemotherapeutic drugs[J].Prostate,2009,69(13):1448-1459. 被引量：1
7Krishna R, Mayer L D. Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs [ J ]. Eur J Pharm Sci,2000,11 (4) :265 - 283. 被引量：1
8Buda G, Orciuolo E, Maggini V,et al. MDR1 modulates apoptosis in CD34 + leukemic cells[ J]. Ann Hematol,2008,87 (12) : 1017 -1018. 被引量：1
9Borst P, Evers R, Kool M, et al. A family of drug transporters : the muhidrug resistance-associated proteins [ J ]. J Natl Cancer Inst, 2000,92 ( 16 ) : 1295 - 1302. 被引量：1
10Litman T, Brangi M, Ross D D, et al. The multidrug-resistant phenotype associated with overexpression of the new ABC half-transporter,MXR(ABCG2) [J]. J Cell Sci,2000,113 ( 11 ) :2011 - 2021. 被引量：1
